TheraCryf (LSE:TCF) Total Assets: £6.62 Mil (As of Sep. 2025)


What is TheraCryf Total Assets?

TheraCryf LSE:TCF Total Assets is £6.62 Mil as of Sep. 2025. The stock has 3 warning signs investors should review.

TheraCryf's Total Assets for the quarter that ended in Sep. 2025 was £6.62 Mil.

During the past 12 months, TheraCryf's average Total Assets Growth Rate was 61.40% per year. During the past 3 years, the average Total Assets Growth Rate was 79.50% per year. During the past 5 years, the average Total Assets Growth Rate was 30.40% per year. During the past 10 years, the average Total Assets Growth Rate was 20.80% per year.

During the past 13 years, TheraCryf's highest 3-Year average Total Assets Growth Rate was 79.50%. The lowest was -6.30%. And the median was 14.50%.

Total Assets is connected with ROA %. TheraCryf's annualized ROA % for the quarter that ended in Sep. 2025 was -36.86%. Total Assets is also linked to Revenue through Asset Turnover. TheraCryf's Asset Turnover for the quarter that ended in Sep. 2025 was 0.00.

TheraCryf  (LSE:TCF) Total Assets Explanation

Total Assets is connected with ROA %.

TheraCryf's annualized ROA % for the quarter that ended in Sep. 2025 is

ROA %=Net Income (Q: Sep. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=-2.626/( (7.63+6.618)/ 2 )
=-2.626/7.124
=-36.86 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

TheraCryf's Asset Turnover for the quarter that ended in Sep. 2025 is

Asset Turnover
=Revenue (Q: Sep. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=0/( (7.63+6.618)/ 2 )
=0/7.124
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

TheraCryf Total Assets Related Terms

TheraCryf Total Assets Historical Data

* Premium members only.

The historical data trend for TheraCryf's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf Total Assets Chart

TheraCryf Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.42 9.64 6.17 3.06 7.63

TheraCryf Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 3.06 3.14 7.63 6.62

TheraCryf Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

TheraCryf's Total Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (A: Mar. 2025 )+Total Liabilities (A: Mar. 2025 )
=5.969+1.661
=7.63

TheraCryf's Total Assets for the quarter that ended in Sep. 2025 is calculated as

Total Assets=Total Equity (Q: Sep. 2025 )+Total Liabilities (Q: Sep. 2025 )
=4.802+1.816
=6.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of £6.62 Mil mean?
TheraCryf (LSE:TCF) has a Total Assets of £6.62 Mil as of Sep. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on TheraCryf and its competitors.
Is TheraCryf's Total Assets too high?
TheraCryf's current Total Assets is £6.62 Mil.
How does TheraCryf's Total Assets compare to VRTX and REGN?
TheraCryf's Total Assets of £6.62 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on TheraCryf and its competitors. TheraCryf's current Total Assets is £6.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TheraCryf stock overvalued right now?
TheraCryf (LSE:TCF) has a current Total Assets of £6.62 Mil. The current Total Assets is £6.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For TheraCryf (LSE:TCF), the current Total Assets is £6.62 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TheraCryf Business Description

Address Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.